Sacituzumab govitecan

Trodelvy

BrazilAuthorisedAuthorised 17 Oct 2022

In other countries

The same active substances on other registers, the same brand first.

TrodelvyCanada · 180 MG / VIAL · Powder For Solution · Gilead Sciences Canada INCSame brand
Trodelvy 200 MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 200 mg · polvo para concentrado para solución para perfusión · Gilead Sciences Ireland Unlimited CompanySame brand
Trodelvy 200 MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 200 mg · polvo para concentrado para solución para perfusión · Gilead Sciences Ireland Unlimited CompanySame brand
TrodelvyEuropean Union · Gilead Sciences Ireland UCSame brand
TrodelvyCroatiaSame brand
TrodelvyItaly · Polvere per concentrato per soluzione per infusione · Gilead Sciences Ireland UcSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Sacituzumab govitecan

Trodelvy

BrazilAuthorisedAuthorised 17 Oct 2022

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Trodelvy 200 mg poeder voor concentraat voor oplossing voor infusieNetherlands · Poeder voor concentraat voor oplossing voor infusie · Gilead Sciences Ireland UC

TrodelvySaudi Arabia · BSP Pharmaceuticals

Trodelvy Powder for Solution for Infusion 180 MG/VialSingapore · 180 mg / vial · injection, powder, lyophilized, for solution · Gilead Sciences Singapore Pte. LTD.

TrodelvyUnited States · 180MG · injectable · Immunomedics INC

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Anvisa, Brazil

Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.

Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Sacituzumab govitecan
Register: Brazil (Anvisa)
Status: Authorised
Status in the register: Ativo
Authorised: 17 Oct 2022
Registration: 109290012
Marketing authorisation holder: Gilead Sciences Farmaceutica do Brasil Ltda
ATC code: L01XC
Group: Antineoplastic and immunomodulating agents
Procedure: Registered